Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Instagram Outage Disrupts Thousands of U.S. Users 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
WATERTOWN, Mass., April 25, 2017 -- Exergen Corporation announces the availability of new professional Temporal Artery Thermometer TAT-5000S models connected to leading vital signs monitors. The new TemporalScanner models are available in six different variations to meet a variety of major vital signs monitor requirements, all supporting the use and advancement of Electronic Medical Records (EMR).
The connection of the TemporalScanner, an award-winning, breakthrough medical thermometer supported by more than 70 peer-reviewed published studies for accurate, completely non-invasive temperature assessment, now eliminates the need for manual entry of data, when connected to vital signs monitors. This significantly aids in the organization, security and confidentiality of patient records. In addition, the connected Exergen TAT models provide convenience and speed for the clinician.
“Through the addition of these new models, we are able to meet the demands of hospitals and clinics for fast, accurate, non-invasive thermometers connected to vital signs monitors, which all automatically record patient data, saving time, improving record accuracy and security, and reducing costs,” said Francesco Pompei, Ph.D., CEO of Exergen Corporation. “Our focus on patient comfort and security speaks to our commitment of introducing new connected models of TATs for vital signs monitors,” added Dr. Pompei.
Exergen Corporation is dedicated to improving and increasing quality, efficiency and accuracy of temperature taking in patient records. With more than 70 published studies supporting its accuracy, the TemporalScanner helps improve patient outcomes while improving patient and clinician experience. The connected models are now available with eight leading vital signs monitors (see http://www.exergen.com//tat5000s).
ABOUT EXERGEN CORPORATION
Exergen manufactures and markets two series of the TemporalScanner thermometer: a professional version for hospitals and clinics, and a consumer version sold in major retailers nationwide. More than two billion temperatures are taken each year with TemporalScanners. Used in thousands of hospitals and clinics across the country as well as in millions of homes, TemporalScanners are the #1 preference of pediatricians, #1 preference of nurses, and #1 selling retail thermometer. The Exergen TemporalScanner's accuracy is supported by more than 70 peer-reviewed published studies covering all ages from preterm infants to geriatrics and all care areas from hospitals to homes. For additional information, visit www.exergen.com.
Contact: Victoria Day Rosica Public Relations [email protected] P: 201.843.5600 F: 201.843.5680 21-00 Route 208 South Fair Lawn, NJ 07410
